Recent developments and prospects in high-field MR

作者: A. Bacci , R. Agati , M. Leonardi

DOI: 10.1007/3-540-31776-7_11

关键词: SignalSpin–lattice relaxationContrast (vision)Field (physics)Field strengthMaterials scienceMagnetic resonance spectroscopic imagingRelaxation (NMR)Medical imagingNuclear magnetic resonance

摘要: During recent years much effort has been put into detecting and classifying disease states, MR imaging a very important tool in this respect. Up to now, increasing the gradient strength only strategy for meeting demands of advanced diagnostic applications. This is limited by physical, economic, andmedical considerations: technically difficult, associated with significant hardware costs risk inducing unwanted side effects such as peripheral neurostimulation. The main advantage high-field improved signal-to-noise ratio, which scales approximately linearly field from 1.5 T 3 T. signal can be used generatemore accurate spatial representation or speed up times, depending on specific application. Higher strengths change tissue contrast parameters. T1 relaxation time increased 30%, whereas T2 T2* times are decreased about 15% [37]. Increasing also doubles chemical shift susceptibility. spectroscopy benefits considerably spectral resolution possible MR, images acquired demonstrate enhanced sensitivity blood oxygen level-dependent (BOLD) effect [77]. On other hand, heating induced radiofrequency power disadvantage use TMR. In fact, RF absorption rate quadruples when increases most attempt circumvent these limitations parallel MRI.

参考文章(62)
Jörg F. Debatin, Thomas M. Grist, Martin R. Prince, 3D Contrast MR Angiography ,(1997)
Maite Lewin, Nadia Carlesso, Ching-Hsuan Tung, Xiao-Wu Tang, David Cory, David T Scadden, Ralph Weissleder, None, Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nature Biotechnology. ,vol. 18, pp. 410- 414 ,(2000) , 10.1038/74464
Arvind P. Pathak, Barjor Gimi, Kristine Glunde, Ellen Ackerstaff, Dmitri Artemov, Zaver M. Bhujwalla, Molecular and Functional Imaging of Cancer: Advances in MRI and MRS Methods in Enzymology. ,vol. 386, pp. 3- 60 ,(2004) , 10.1016/S0076-6879(04)86001-4
Dmitri Artemov, Noriko Mori, Rajani Ravi, Zaver M. Bhujwalla, Magnetic Resonance Molecular Imaging of the HER-2/neu Receptor Cancer Research. ,vol. 63, pp. 2723- 2727 ,(2003)
R L Ehman, M T McNamara, R C Brasch, J P Felmlee, J E Gray, C B Higgins, Influence of physiologic motion on the appearance of tissue in MR images. Radiology. ,vol. 159, pp. 777- 782 ,(1986) , 10.1148/RADIOLOGY.159.3.3704156
Ulrike Dydak, Markus Weiger, Klaas P. Pruessmann, Dieter Meier, Peter Boesiger, Sensitivity-encoded spectroscopic imaging. Magnetic Resonance in Medicine. ,vol. 46, pp. 713- 722 ,(2001) , 10.1002/MRM.1250
Michael A. Ohliger, Aaron K. Grant, Daniel K. Sodickson, Ultimate intrinsic signal-to-noise ratio for parallel MRI: electromagnetic field considerations. Magnetic Resonance in Medicine. ,vol. 50, pp. 1018- 1030 ,(2003) , 10.1002/MRM.10597
Dana R. Abendschein, Gregory M. Lanza, Samuel A. Wickline, Anne M. Morawski, Patrick M. Winter, Kathryn C. Crowder, Shelton D. Caruthers, Ralph W. Fuhrhop, Michael J. Scott, J. David Robertson, Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI Magnetic Resonance in Medicine. ,vol. 51, pp. 480- 486 ,(2004) , 10.1002/MRM.20010
Hanns-Joachim Weinmann, Wolfgang Ebert, Bernd Misselwitz, Heribert Schmitt-Willich, Tissue-specific MR contrast agents. European Journal of Radiology. ,vol. 46, pp. 33- 44 ,(2003) , 10.1016/S0720-048X(02)00332-7
J.W.M. Bulte, R.A. Brooks, B.M. Moskowitz, L.H. Bryant,, J.A. Frank, Relaxometry and magnetometry of the MR contrast agent MION-46L. Magnetic Resonance in Medicine. ,vol. 42, pp. 379- 384 ,(1999) , 10.1002/(SICI)1522-2594(199908)42:2<379::AID-MRM20>3.0.CO;2-L